权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Prediction Model: Breast Cancer in Women Irradiated for a Pediatric Malignancy

预测模型：因儿童恶性肿瘤接受放射治疗的女性乳腺癌

基本信息

批准号：
8433993
负责人：
CHAYA MOSKOWITZ
金额：
$ 34.77万
依托单位：
SLOAN-KETTERING INST CAN RESEARCH
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
起止时间：
2010-04-01 至 2015-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8433993
关键词：
Abdomen Accounting Address Age Age at First Live Birth Age at Menarche Alkylating Agents American Atypical hyperplasia Biopsy Body mass index Breast Breast Cancer Detection Breast Cancer Model Breast Cancer Risk Assessment Tool Breast Cancer Risk Factor Canada Cancer Survivor Chest Child Childhood Childhood Cancer Survivor Study Children&apos s Oncology Group Clinical Computer Assisted Conflict (Psychology)Contraceptive Usage Data Data Set Diagnosis Disease Dose Dose-Limiting Family Female First Degree Relative Future Goals Guidelines Hormone replacement therapy Hormones Individual International Knowledge Late Effects Literature Lung Magnetic Resonance Imaging Malignant Childhood Neoplasm Malignant Neoplasms Mammary Gland Parenchyma Mammography Mantle Field Mediastinal Menopause Modeling Morbidity - disease rate Oral Contraceptives Outcome Ovarian Participant Patients Pelvis Physicians Population Population Study Premature Mortality Prevention Prevention strategy Probability Quality of life Radiation Radiation therapy Recommendation Recording of previous events Registries Relative (related person)Reproductive History Research Project Grants Resources Risk Risk Factors Spinal Staging Survival Rate Survivors Therapeutic Time United States Validation Whole-Body Irradiation Woman base cancer diagnosis cancer risk cancer therapy clinical practice cohort design improved malignant breast neoplasm mortality public health relevance screening standard of care tool user friendly software

项目摘要

DESCRIPTION (provided by applicant): Survivors of a pediatric malignancy are at risk for serious long-term morbidity and premature mortality related to their treatment. Women who were treated with chest radiation for their childhood cancer have an increased risk of developing breast cancer at a young age. We use the term chest radiation to refer to radiation that includes the following fields: mantle, mediastinal, lung, total body irradiation, or spinal. Models for predicting the absolute risk of breast cancer, such as the well-known Gail model, have been used extensively to advise patients on their individual risk of developing breast cancer and to design prevention trials. The majority of these risk calculators are not immediately applicable to survivors of a previous malignancy who have a risk that is modified by previous treatments. Moreover, there is conflicting evidence as to whether various non-treatment related factors, including the traditional breast cancer risk factors, are associated with the risk of breast cancer in these women. The traditional risk factors include age, age at menarche, age at birth of first live child, number of first-degree relatives with breast cancer, number of previous breast biopsies, and history of atypical hyperplasia. We propose to utilize the unique resources of the North American Childhood Cancer Survivor Study (CCSS) and the Dutch LATe Effect Registry (LATER) cohorts. Our first aim is to develop a risk prediction model that integrates chest radiation dose and volume, treatment-related exposures, the traditional risk factors, and other possible risk factors such as age at menopause, body mass index, the number of years with intact ovarian function after radiotherapy, and use of hormone replacement or oral contraceptive therapy, in order to estimate the individualized absolute risk of breast cancer for women who were treated with chest radiation for a childhood cancer. The model will be developed using the original CCSS cohort in which there are 1,677 female participants who were treated with chest radiation and would be included in this analysis. Of these 1,677 women, 187 women had developed breast cancer by the time of this application. Our second aim is to validate the prediction model on independent data. The validation cohort will consist of about 1225 female participants in the expanded CCSS cohort and 1087 female participants in the Dutch LATER cohort. We estimate that approximately 100 of these women will have breast cancer. The third aim is to create and disseminate a risk calculator that provides computer-assisted risk prediction. Our objective is to present a tool in an easily accessible format and disseminate it for clinical use by physicians and patients. The long-term goals of this project are to provide a means for facilitating conversations between physicians and their patients about appropriate screening and preventive strategies and to help refine screening recommendations for this population.

描述(由申请人提供)：儿童恶性肿瘤的幸存者面临与其治疗相关的严重的长期发病率和过早死亡的风险。因儿童癌症而接受胸部放射治疗的女性在年轻时患乳腺癌的风险更高。我们使用术语胸部辐射来指包括以下领域的辐射：外套膜、纵隔、肺、全身照射或脊髓。预测乳腺癌绝对风险的模型，如著名的盖尔模型，已被广泛用于建议患者患乳腺癌的个人风险，并设计预防试验。这些风险计算器中的大多数并不立即适用于先前恶性肿瘤的幸存者，他们的风险被以前的治疗方法改变了。此外，关于各种非治疗相关因素，包括传统的乳腺癌风险因素，是否与这些女性的乳腺癌风险有关，存在相互矛盾的证据。传统的危险因素包括年龄、月经初潮年龄、第一个活着的孩子出生时的年龄、患有乳腺癌的一级亲属的数量、既往乳腺活检的数量以及不典型增生的病史。我们建议利用北美儿童癌症幸存者研究(CCSS)和荷兰迟发效应登记(LATH)队列的独特资源。我们的第一个目标是建立一个风险预测模型，该模型综合了胸部放射剂量和体积、治疗相关暴露、传统危险因素以及其他可能的危险因素，如绝经年龄、体重指数、放疗后卵巢功能完整的年数、激素替代治疗或口服避孕药的使用，以评估因儿童癌症而接受胸部放射治疗的妇女患乳腺癌的个体化绝对风险。该模型将使用最初的CCSS队列进行开发，其中有1,677名女性参与者接受了胸部放射治疗，并将被包括在这项分析中。在这1677名妇女中，187名妇女在申请时已经患上了乳腺癌。我们的第二个目标是在独立数据上验证预测模型。验证队列将包括扩大后的CCSS队列中的约1225名女性参与者和荷兰后来队列中的1087名女性参与者。我们估计，这些女性中大约有100人会患乳腺癌。第三个目标是创建和传播一个提供计算机辅助风险预测的风险计算器。我们的目标是以一种易于访问的形式提供一种工具，并将其传播给医生和患者进行临床使用。该项目的长期目标是提供一种手段，促进医生和患者之间就适当的筛查和预防策略进行对话，并帮助完善针对这一人群的筛查建议。